Unlock the potential of Glenmark Pharmaceutical’s stock with expert-estimated price targets for 2024, 2025, 2026, 2028, 2030, 2040 and 2050. Stay ahead of market trends and make informed investment decisions with our comprehensive analysis.
Glenmark Pharmaceutical is a global company founded in 1977 by Gracias Saldanha, which manufactures generic and OTC medicines. Its main areas of work are dermatology, oncology, and respiratory. In the initial phase it sold its products in India, Russia and Africa. Currently, it has 10 world-class manufacturing companies spread across 5 continents, 4 research centers and operations in more than 80 countries. As of 2023, the company has 15,556 employees.
Glenmark Pharmaceutical has been awarded the EY Entrepreneur of the Year (Life Sciences and Healthcare category, India) in 2017. Apart from this, the company has also been honored with the India Pharma Leader Award by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India in 2015.
Glenmark Listing date
Glenmark Pharmaceutical was listed on NSE and BSE on 7 February 2000. At the time of listing its share price was Rs 24.95 and today on 17 May 2024 its share price is Rs 1021.50.
Parameter
Value
Face Value of Equity Shares
1
Market Lot of Equity Shares
1
Listed On
BSE Ltd. , National Stock Exchange of India Ltd.
Listing date
7 Feb 2000
BSE Code
532296
NSE Code
GLENMARK
BSE Group
A
Glenmark Share Price History
Since its listing in the stock exchange, there has been a continuous growth in its share price. When it was listed in 2000, the share price of Glenmark Pharma was Rs 24.95 and today its shares have increased by 3994% to Rs 1021.50. Let us see the growth or loss of Glenmark Pharma’s share in a few years through a chart.
Glenmark Share Price growth chart
Price Performance
% growth
1 Week
-1.33%
1 Month
-3.46%
3 Months
24.39%
YTD
18.03%
1 Year
65.79%
3 Years
65.69%
Glenmark Pharmaceutical Fundamental
Fundamental and technical analysis of the company shows that the company can give good returns in future. Long term investors should focus on its shares.
Company Name
Glenmark Pharma Ltd.
Sector
Pharmaceuticals & Drugs
Website
glenmarkpharma.com
Mrket Cap
28,392Cr
Listing At
NSE and BSE
52 Week High
1,098.00
52 Week Low
581.00
P/E Ratio (TTM)
-39.89
P/B Ratio
3.04
Face Value
1
Dividend Yield
0.25%
Book Value Per Share
330.53
Net Profit (Anual)
1,208.77
EPS (TTM)
-25.22
Net Sales
9206.60Cr
Sales Growth
5.14%
ROE
6.48%
ROCE
10.81
Profit Growth
28.96%
All data is taken from moneycontrol
Glenmark Pharmaceutical Profit/Loss – Last 5 Years Report
Glenmark Pharmaceutical Income Report
Income
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
12 mths
12 mths
12 mths
12 mths
12 mths
Revenue From Operations [Gross]
8,019.67
8,017.38
7,450.91
6,491.20
6,131.14
Revenue From Operations [Net]
8,019.67
8,017.38
7,450.91
6,491.20
6,131.14
Other Operating Revenues
201.00
124.20
117.02
221.43
173.73
Total Operating Revenues
8,220.66
8,141.58
7,567.93
6,712.63
6,304.87
Other Income
985.94
614.63
396.24
606.79
475.61
Total Revenue
9,206.60
8,756.21
7,964.17
7,319.42
6,780.48
All data is taken from moneycontrol
Glenmark Pharmaceutical Expenses
Expense
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
12 mths
12 mths
12 mths
12 mths
12 mths
Cost Of Materials Consumed
3,035.88
2,993.04
2,678.26
2,251.98
1,585.85
Purchase Of Stock-In Trade
391.19
481.62
315.96
365.24
301.30
Changes In Inventories Of FG,WIP And Stock-In Trade
-31.37
-16.13
5.24
48.77
471.81
Employee Benefit Expenses
1,346.51
1,193.20
1,107.40
1,072.33
969.98
Finance Costs
206.82
236.04
265.90
256.39
223.81
Depreciation And Amortisation Expenses
184.15
159.70
150.82
138.54
106.28
Other Expenses
2,005.68
1,801.64
1,570.74
1,670.08
1,648.45
Total Expenses
7,138.86
6,849.10
6,094.31
5,803.33
5,307.48
All data is taken from moneycontrol
Glenmark Pharmaceutical Profit/Loss
Profit/Loss
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
12 mths
12 mths
12 mths
12 mths
12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax
2,067.74
1,907.11
1,869.87
1,516.09
1,473.00
Profit/Loss Before Tax
1,571.87
2,337.45
1,943.76
1,534.64
1,818.18
Profit/Loss From Continuing Operations
1,208.77
1,997.79
1,649.45
1,354.55
1,488.30
Profit/Loss For The Period
1,208.77
1,997.79
1,649.45
1,354.55
1,622.11
Other Additional Information
EARNINGS PER SHARE
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
12 mths
12 mths
12 mths
12 mths
12 mths
Basic EPS (Rs.)
42.84
70.80
58.46
48.00
57.49
Diluted EPS (Rs.)
42.84
70.80
58.46
48.00
57.49
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend
70.54
70.54
70.54
68.03
68.03
Equity Dividend Rate (%)
250.00
250.00
250.00
250.00
200.00
All data is taken from moneycontrol
Glenmark Pharma Ltd. Balance Sheet – Last 5 Years Report:
Glenmark Pharma Ltd. listed on NSE and BSE. There are many brokers registered by SEBI to buy shares. Shares of any company can be easily bought and sold through these brokers. Some popular brokers are –
Zerodha
Groww
Angel One
Upstox
Disclaimer – Please note that we are not SEBI-registered advisors. Our post is for educational purposes only. Therefore, before investing in any share, take advice from a SEBI certified expert. If you invest, you yourself will be responsible for your profit and loss, not us.